A roadmap for multi-omics data integration using deep learning
High-throughput next-generation sequencing now makes it possible to generate a vast
amount of multi-omics data for various applications. These data have revolutionized …
amount of multi-omics data for various applications. These data have revolutionized …
[HTML][HTML] The role of vitamin D in breast cancer risk and progression
J Vanhevel, L Verlinden, S Doms… - Endocrine-related …, 2022 - erc.bioscientifica.com
The active form of vitamin D 3, 1, 25-dihydroxyvitamin D 3 (1, 25 (OH) 2 D 3), is primarily
known as a key regulator of calcium and phosphate homeostasis. It exerts its biological …
known as a key regulator of calcium and phosphate homeostasis. It exerts its biological …
[HTML][HTML] Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials
HN Girithar, A Staats Pires, SB Ahn… - British Journal of …, 2023 - nature.com
Breast cancer (BrCa) is the leading cause of cancer incidence and mortality in women
worldwide. While BrCa treatment has been shown to be highly successful if detected at an …
worldwide. While BrCa treatment has been shown to be highly successful if detected at an …
[HTML][HTML] Antibody-drug conjugates for the treatment of HER2-positive breast cancer
MK Najjar, SG Manore, AT Regua, HW Lo - Genes, 2022 - mdpi.com
Human epidermal growth factor receptor 2 (HER2) receptor tyrosine kinase is
overexpressed in 20–30% of breast cancers and is associated with poor prognosis and …
overexpressed in 20–30% of breast cancers and is associated with poor prognosis and …
[HTML][HTML] Survival analysis in breast cancer using proteomic data from four independent datasets
Breast cancer clinical treatment selection is based on the immunohistochemical
determination of four protein biomarkers: ESR1, PGR, HER2, and MKI67. Our aim was to …
determination of four protein biomarkers: ESR1, PGR, HER2, and MKI67. Our aim was to …
[HTML][HTML] Targeted therapy and mechanisms of drug resistance in breast cancer
Simple Summary Internationally, in women, breast cancer (BC) is the most common cancer
type and is the leading cause of cancer-related death. There are two main histological …
type and is the leading cause of cancer-related death. There are two main histological …
[HTML][HTML] Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence—A Systematic Review
L Bouz Mkabaah, MG Davey, JC Lennon… - International Journal of …, 2023 - mdpi.com
Identifying patients likely to develop breast cancer recurrence remains a challenge. Thus,
the discovery of biomarkers capable of diagnosing recurrence is of the utmost importance …
the discovery of biomarkers capable of diagnosing recurrence is of the utmost importance …
[HTML][HTML] Notch signaling in breast tumor microenvironment as mediator of drug resistance
A Chimento, M D'Amico, V Pezzi… - International Journal of …, 2022 - mdpi.com
Notch signaling dysregulation encourages breast cancer progression through different
mechanisms such as stem cell maintenance, cell proliferation and migration/invasion …
mechanisms such as stem cell maintenance, cell proliferation and migration/invasion …
[HTML][HTML] Estrogen receptors-mediated apoptosis in hormone-dependent cancers
A Chimento, A De Luca, P Avena, F De Amicis… - International journal of …, 2022 - mdpi.com
It is known that estrogen stimulates growth and inhibits apoptosis through estrogen receptor
(ER)-mediated mechanisms in many cancer cell types. Interestingly, there is strong evidence …
(ER)-mediated mechanisms in many cancer cell types. Interestingly, there is strong evidence …
[HTML][HTML] Cannabinoids in breast cancer: differential susceptibility according to subtype
CF Almeida, N Teixeira, G Correia-da-Silva, C Amaral - Molecules, 2021 - mdpi.com
Although cannabinoids have been used for centuries for diverse pathological conditions,
recently, their clinical interest and application have emerged due to their diverse …
recently, their clinical interest and application have emerged due to their diverse …